Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 9;58(19):1880-1897.e11.
doi: 10.1016/j.devcel.2023.08.005. Epub 2023 Aug 28.

DYRK3 enables secretory trafficking by maintaining the liquid-like state of ER exit sites

Affiliations
Free article

DYRK3 enables secretory trafficking by maintaining the liquid-like state of ER exit sites

Raffaella Gallo et al. Dev Cell. .
Free article

Abstract

The dual-specificity kinase DYRK3 controls the formation and dissolution of multiple biomolecular condensates, regulating processes including stress recovery and mitotic progression. Here, we report that DYRK3 functionally interacts with proteins associated with endoplasmic reticulum (ER) exit sites (ERESs) and that inhibition of DYRK3 perturbs the organization of the ERES-Golgi interface and secretory trafficking. DYRK3-mediated regulation of ERES depends on the N-terminal intrinsically disordered region (IDR) of the peripheral membrane protein SEC16A, which co-phase separates with ERES components to form liquid-like condensates on the surface of the ER. By modulating the liquid-like properties of ERES, we show that their physical state is essential for functional cargo trafficking through the early secretory pathway. Our findings support a mechanism whereby phosphorylation by DYRK3 and its reversal by serine-threonine phosphatases regulate the material properties of ERES to create a favorable physicochemical environment for directional membrane traffic in eukaryotic cells.

Keywords: COPII; DYRK3; ERES; LLPS; SEC16A; kinase; material properties; optogenetics; phase separation; secretory pathway.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests L.P. consults for Dewpoint Therapeutics and has ownership interest in Sagimet Biosciences and Apricot Therapeutics.

Similar articles

Cited by

LinkOut - more resources